Biorestorative Therapies | SCHEDULE 13G/A: Others
Biorestorative Therapies | SCHEDULE 13G/A: Others
Biorestorative Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Biorestorative Therapies | 8-K: BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
Biorestorative Therapies | 10-Q: Q3 2024 Earnings Report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 424B5: Prospectus
Biorestorative Therapies | 10-K/A: Annual report (Amendment)
Biorestorative Therapies | 4: Statement of changes in beneficial ownership of securities-10% Owner Broadrick Dale
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 10-Q: Q2 2024 Earnings Report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | DEF 14A: Definitive information statements
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | SCHEDULE 13G: Others
Biorestorative Therapies | 10-Q: Q1 2024 Earnings Report
Biorestorative Therapies | 10-K/A: Annual report (Amendment)
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report